Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.

Future oncology (London, England) - 1 Jun 2018

Tan Dan, Pang Feng-Mei, Li Dan, Zhang Longbo, Wu Jun, Liu Zhao-Qian, Li Xi, Yan Han

Abstract excerpt

AIM: To confirm whether the expression level of Fn14 could affect progression or prognosis of glioma patients. METHODS: Glioma cohorts in The Cancer Genome Atlas, Gene Expression Omnibus and Chinese Glioma Genome Atlas databases were comprehensively analyzed. RESULTS: Low-grade patients had lower expression level of Fn14, while patients with higher expression of Fn14 tended to harbor shorter overall survival and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Dacarbazine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Datasets as Topic

Share to Disease-Free Survival

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Temozolomide

Source

Identifiers

PMID: 29741404
DOI: 10.2217/fon-2017-0598

Genes

IDH1
IDH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.PMID 29741404Read ↗

Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.Semantic proximity Read ↗

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read ↗

Pivotal Role of FBXW4 in Glioma Progression and Prognosis.Semantic proximity Read ↗

DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in gliomaSemantic proximity Read ↗

DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progressionSemantic proximity Read ↗

ZMYND8 as a novel diagnostic and prognostic biomarker in GliomaSemantic proximity Read ↗

EMILIN2 Correlated With Its Methylation and Immune Infiltration Could Be an Independent Prognostic Biomarker in LGGSemantic proximity Read ↗

ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.Semantic proximity Read ↗

Expression and prognostic role of E2F transcription factors in high‐grade gliomaSemantic proximity Read ↗

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with gliomaSemantic proximity Read ↗

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growthSemantic proximity Read ↗

EFNA4 as a potential prognostic biomarker and therapeutic target for GBMLGGSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.